Chief Scientist & Head of External Research and Development, GSK Vaccines
Director, Vaccine Research Center, NIH/NIAID
Chief, Vaccine Branch, Center for Cancer Research, National Cancer Institute
Director, HMFP - Division of Vaccine Research
Former Senior Vice President R&D of Sanofi Pasteur & Owner, MDW Consultant LLC
Chief Executive Officer, Bill & Melinda Gates Medical Research Institute
Chief Executive and Scientific Officer, Sanaria Inc.
Chief Executive and Scientific Officer, InDevR, Inc.
Director, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center
Chief, Biodefense Research Section, NIH/NIAID
Chief Executive and Scientific Officer, IRT BIOASTER
Chairman Emeritus. Chief Executive Officer, President, Chairman & co-founder, Biological Mimetics, Inc.
President and Chief Executive Officer, Biologics Consulting
Member, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center
"Congratulations. You have really made progress, and the meeting is getting better each time"
"Thank you, I learned much at this meeting and made many new contacts"
"I enjoyed the meeting"
"The meeting is getting better every year. Great work in organizing the speaker line"
After 35 years of research, the Colombian scientist Manuel Elkin Patarroyo and his team at the Institute of Immunology of Colombia (FIDIC) s Foundation and ready for human testing its new vaccine against malaria in seven countries in sub – Saharan Africa.
The 3rd International Conference on Vaccines Research and Development (Vaccines R&D 2017) at the Sheraton Reston Hotel, Reston located within the Washington, D.C. metropolitan area, brought together more than 250 experts of the leading institutes and organizations to share their knowledge.